Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) (COMRADE-C)
This study is currently recruiting participants.
Verified March 2013 by Novartis
Study NCT01396083
Information provided by Novartis
First Received on July 14, 2011.
Last Updated on March 28, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
